Kelderman Kim
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Kelderman Kim. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TECH | Chief Executive Officer | Tax Withholding | 2,303 | $62.57 | $144,099 | Nov 3, 2025 |
| TECH | Chief Executive Officer | Option Exercise | 8,543 | — | — | Aug 15, 2025 |
| TECH | Chief Executive Officer | Option Exercise | 48,176 | $44.33 | $2,135,642 | Jul 22, 2025 |
| TECH | Chief Executive Officer | Option Exercise | 36,132 | $44.33 | $1,601,732 | Jul 15, 2025 |
| TECH | Chief Executive Officer | Sale | 1,661 | $77.95 | $129,475 | Jan 27, 2025 |
| TECH | Chief Executive Officer | Tax Withholding | 2,430 | $75.31 | $183,003 | Nov 1, 2024 |
| TECH | Chief Executive Officer | Option Exercise | 1,492 | $66.97 | $99,919 | Aug 29, 2024 |
| TECH | Chief Executive Officer | Option Exercise | 14,000 | $37.70 | $527,800 | Jul 31, 2024 |
| TECH | Chief Operating Officer | Award / Grant | 14,196 | — | — | Nov 1, 2023 |
| TECH | Pres. Diagnostics & Genom | Option Exercise | 2,100 | $47.60 | $99,960 | Aug 24, 2023 |
| TECH | Pres. Diagnostics & Genom | Tax Withholding | 4,139 | $82.17 | $340,102 | Aug 5, 2023 |
| TECH | Pres. Diagnostics & Genom | Option Exercise | 663 | $150.78 | $99,967 | Aug 23, 2022 |
| TECH | Pres. Diagnostics & Genom | Tax Withholding | 1,214 | $382.97 | $464,926 | Aug 7, 2022 |
| TECH | Pres. Diagnostics & Genom | Option Exercise | 1,989 | $150.78 | $299,901 | Feb 8, 2022 |
| TECH | Pres. Diagnostics & Genom | Option Exercise | 500 | $150.78 | $75,390 | Nov 19, 2021 |
| TECH | Pres. Diagnostics & Genom | Sale | 822 | $529.04 | $434,871 | Sep 22, 2021 |
| TECH | Pres. Diagnostics & Genom | Option Exercise | 1,691 | — | — | Aug 8, 2021 |
| TECH | Pres. Diagnostics & Genom | Sale | 811 | $433.00 | $351,163 | Jun 9, 2021 |
| TECH | Pres. Diagnostics & Genom | Sale | 845 | $424.00 | $358,280 | May 25, 2021 |
| TECH | Pres. Diagnostics & Genom | Tax Withholding | 856 | $427.49 | $365,931 | May 1, 2021 |
| TECH | Pres. Diagnostics & Genom | Sale | 823 | $388.45 | $319,694 | Feb 5, 2021 |
| TECH | Pres. Diagnostics & Genom | Tax Withholding | 821 | $227.54 | $186,810 | May 1, 2020 |
| TECH | President, Diagnostics & Genom | Option Exercise | 1,667 | $202.13 | $336,951 | May 1, 2019 |